Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation
Eike-Benjamin Braune1, Anita Seshire2, Urban Lendahl3
1Department of Cell and Molecular Biology, Karolinska Institute, SE-171 77 Stockholm, Sweden. eike-benjamin.braune@ki.se.
Abstract:
Breast cancer is the second leading cause of cancer deaths among women in the world. Treatment has been improved and, in combination with early detection, this has resulted in reduced mortality rates. Further improvement in therapy development is however warranted. This will be particularly important for certain sub-classes of breast cancer, such as triple-negative breast cancer, where currently no specific therapies are available. An important therapy development focus emerges from the notion that dysregulation of two major signaling pathways, Notch and Wnt signaling, are major drivers for breast cancer development. In this review, we discuss recent insights into the Notch and Wnt signaling pathways and into how they act synergistically both in normal development and cancer. We also discuss how dysregulation of the two pathways contributes to breast cancer and strategies to develop novel breast cancer therapies starting from a Notch and Wnt dysregulation perspective.
Insights
This review explores how Notch and Wnt signaling pathways drive breast cancer, especially triple-negative breast cancer. Understanding their synergistic roles offers new therapeutic strategies for improved breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Breast cancer is a leading cause of cancer death in women worldwide.
- Improved treatments and early detection have reduced mortality, but further advancements are needed.
- Triple-negative breast cancer lacks targeted therapies, highlighting the need for novel treatment strategies.
Purpose of the Study:
- To review recent insights into Notch and Wnt signaling pathways in breast cancer.
- To discuss the synergistic roles of Notch and Wnt signaling in normal development and cancer.
- To explore therapeutic strategies targeting Notch and Wnt pathway dysregulation for breast cancer treatment.
Main Methods:
- Literature review of current research on Notch and Wnt signaling in breast cancer.
- Analysis of the synergistic interactions between Notch and Wnt pathways.
- Discussion of therapeutic approaches based on targeting these signaling pathways.
Main Results:
- Dysregulation of Notch and Wnt signaling pathways are key drivers of breast cancer development.
- These pathways interact synergistically in both normal development and oncogenesis.
- Targeting Notch and Wnt dysregulation presents a promising avenue for novel breast cancer therapies.
Conclusions:
- Understanding the interplay of Notch and Wnt signaling is crucial for advancing breast cancer therapy.
- Novel therapeutic strategies can be developed by targeting the dysregulated Notch and Wnt pathways.
- This approach holds particular promise for aggressive subtypes like triple-negative breast cancer.
Related Concept Videos
02:33Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
02:33Initiation of Translation
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
02:54Canonical Wnt Signaling Pathway
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:41Non-Canonical Wnt Signaling Pathways